| scholarly article | Q13442814 |
| P50 | author | Cornelia A Lux | Q88653397 |
| Gustav Steinhoff | Q1556424 | ||
| Frank Wiekhorst | Q57010426 | ||
| Robert David | Q88045582 | ||
| Paula Müller | Q88653391 | ||
| Natalia Voronina | Q88653393 | ||
| Frauke Hausburg | Q88653396 | ||
| P2860 | cites work | Progresses towards safe and efficient gene therapy vectors | Q26781432 |
| State-of-the-art human gene therapy: part I. Gene delivery technologies | Q26825575 | ||
| Systematic review: the effects of autologous stem cell therapy for patients with liver disease | Q27024968 | ||
| Autologous immuno magnetically selected CD133+ stem cells in the treatment of no-option critical limb ischemia: clinical and contrast enhanced ultrasound assessed results in eight patients. | Q27303621 | ||
| Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration | Q28207902 | ||
| Assessment and optimization of cell engraftment after transplantation into the heart | Q33680007 | ||
| Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction | Q33746096 | ||
| Revisit complexation between DNA and polyethylenimine — Effect of length of free polycationic chains on gene transfection | Q33860593 | ||
| Preconditioning stem cells for in vivo delivery. | Q33998015 | ||
| Local transplantation of granulocyte colony-stimulating factor-mobilized human peripheral blood mononuclear cells for unhealing bone fractures | Q34022441 | ||
| Early stem cell engraftment predicts late cardiac functional recovery: preclinical insights from molecular imaging | Q34260802 | ||
| Quantitative Magnetic Particle Imaging Monitors the Transplantation, Biodistribution, and Clearance of Stem Cells In Vivo | Q34515367 | ||
| Randomized transcoronary delivery of CD34(+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of ⁹⁹(m)Tc-labeled cells activity | Q34544884 | ||
| Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial | Q34620003 | ||
| miR-146a and miR-150 promote the differentiation of CD133+ cells into T-lymphoid lineage. | Q39152140 | ||
| Insights into the mechanism of magnetofection using MNPs-PEI/pDNA/free PEI magnetofectins | Q39496939 | ||
| Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: A phase I clinical trial. | Q40477293 | ||
| Non-viral magnetic engineering of endothelial cells with microRNA and plasmid-DNA-An optimized targeting approach. | Q40662681 | ||
| One-day kinetics of myocardial engraftment after intracoronary injection of bone marrow mononuclear cells in patients with acute and chronic myocardial infarction | Q41389712 | ||
| Good things come in small packages: Therapeutic anti-tumor immunity induced by microRNA nanoparticles | Q41474711 | ||
| MicroRNAs as new maestro conducting the expanding symphony orchestra of regenerative and reparative medicine | Q42750230 | ||
| Intracellular dynamics of the gene delivery vehicle polyethylenimine during transfection: investigation by two-photon fluorescence correlation spectroscopy | Q44668463 | ||
| Magnetic targeting of cardiosphere-derived stem cells with ferumoxytol nanoparticles for treating rats with myocardial infarction | Q44874644 | ||
| Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application | Q45877889 | ||
| In-vivo comparison of the acute retention of stem cell derivatives and fibroblasts after intramyocardial transplantation in the mouse model | Q46232303 | ||
| Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients. | Q46265702 | ||
| Enhanced thoracic gene delivery by magnetic nanobead-mediated vector | Q46594608 | ||
| Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety | Q46700940 | ||
| Myocardial blood flow and infarct size after CD133+ cell injection in large myocardial infarction with good recanalization and poor reperfusion: results from a randomized controlled trial | Q47388203 | ||
| Synthesis of acid-stabilized iron oxide nanoparticles and comparison for targeting atherosclerotic plaques: evaluation by MRI, quantitative MPS, and TEM alternative to ambiguous Prussian blue iron staining | Q50217728 | ||
| In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart disease | Q50470737 | ||
| Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial | Q50623510 | ||
| Magnetic Field–Based Delivery of Human CD1331 Cells Promotes Functional Recovery After Rat Spinal Cord Injury | Q50666066 | ||
| Impact of short-term liquid storage on human CD133(+) stem cells | Q51737319 | ||
| Mechanisms of polyethylenimine-mediated DNA delivery: free carrier helps to overcome the barrier of cell-surface glycosaminoglycans | Q51766886 | ||
| Selected CD133⁺ progenitor cells to promote angiogenesis in patients with refractory angina: final results of the PROGENITOR randomized trial. | Q53050821 | ||
| Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant. | Q53219986 | ||
| Myocardial homing and coronary endothelial function after autologous blood CD34+ progenitor cells intracoronary injection in the chronic phase of myocardial infarction | Q53355002 | ||
| Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium | Q53453905 | ||
| Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction | Q53491566 | ||
| Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. | Q53526425 | ||
| Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection | Q53566701 | ||
| Intrathecal injection of CD133-positive enriched bone marrow progenitor cells in children with cerebral palsy: feasibility and safety | Q53642844 | ||
| In vivo trafficking and targeted delivery of magnetically labeled stem cells | Q53846483 | ||
| Stem cell transplantation in amyotrophic lateral sclerosis patients: methodological approach, safety, and feasibility | Q56775496 | ||
| Positive selection and transplantation of autologous highly purified CD133(+) stem cells in resistant/relapsed chronic lymphocytic leukemia patients results in rapid hematopoietic reconstitution without an adequate leukemic cell purging | Q56994375 | ||
| Magnetic Tagging Increases Delivery of Circulating Progenitors in Vascular Injury | Q59291971 | ||
| The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering | Q71558484 | ||
| Intracoronary infusion of CD133+ and CD133-CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution | Q79775075 | ||
| Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies | Q79826696 | ||
| Focused magnetic stem cell targeting to the retina using superparamagnetic iron oxide nanoparticles | Q83616230 | ||
| Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: Bone marrow vs. cord blood-derived cells | Q83859481 | ||
| Improved transfection in human mesenchymal stem cells: effective intracellular release of pDNA by magnetic polyplexes | Q86029487 | ||
| Innovative Strategy for MicroRNA Delivery in Human Mesenchymal Stem Cells via Magnetic Nanoparticles | Q34736652 | ||
| Role of microRNAs in vascular diseases, inflammation, and angiogenesis | Q34786294 | ||
| REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem | Q35203746 | ||
| Characterization of magnetic viral complexes for targeted delivery in oncology. | Q35475901 | ||
| Modulation of Gene Expression by Polymer Nanocapsule Delivery of DNA Cassettes Encoding Small RNAs | Q35650064 | ||
| MicroRNA delivery for regenerative medicine | Q35863950 | ||
| In vitro and in vivo expansion of hematopoietic stem cells. | Q35892103 | ||
| Magnetically Targeted Stem Cell Delivery for Regenerative Medicine | Q36138808 | ||
| Genetic modification of hematopoietic stem cells with nonviral systems: past progress and future prospects | Q36288888 | ||
| Certain types of iron oxide nanoparticles are not suited to passively target inflammatory cells that infiltrate the brain in response to stroke | Q36839949 | ||
| Magnetic Targeting of Human Peripheral Blood CD133+Cells for Skeletal Muscle Regeneration | Q36947670 | ||
| Systems approaches to preventing transplanted cell death in cardiac repair. | Q36984663 | ||
| Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection | Q37108152 | ||
| Polymer-based gene delivery: a current review on the uptake and intracellular trafficking of polyplexes. | Q37294155 | ||
| Progress in microRNA delivery | Q37478933 | ||
| Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients | Q37568677 | ||
| Mesenchymal stromal cells to treat cardiovascular disease: strategies to improve survival and therapeutic results | Q37709124 | ||
| CD133(+) cells isolated from various sources and their role in future clinical perspectives | Q37798837 | ||
| Role of microRNAs in stem/progenitor cells and cardiovascular repair | Q37963826 | ||
| Is it time to revisit our current hematopoietic progenitor cell quantification methods in the clinic? | Q37964485 | ||
| Revisiting cardiovascular regeneration with bone marrow‐derived angiogenic and vasculogenic cells | Q37976449 | ||
| Hematopoietic stem cell expansion: challenges and opportunities. | Q38035450 | ||
| Polyethylenimines for siRNA and miRNA delivery in vivo | Q38110474 | ||
| Improving survival and efficacy of pluripotent stem cell-derived cardiac grafts | Q38151937 | ||
| The CD133+ cell as advanced medicinal product for myocardial and limb ischemia. | Q38228388 | ||
| Recent developments in nucleic acid delivery with polyethylenimines | Q38269563 | ||
| MicroRNA-mediated immune modulation as a therapeutic strategy in host-implant integration | Q38507872 | ||
| The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy | Q38535126 | ||
| Magnetic iron oxide nanoparticles: Recent trends in design and synthesis of magnetoresponsive nanosystems | Q38567036 | ||
| Stem cells - biological update and cell therapy progress | Q38648343 | ||
| Magnetic Particle Spectroscopy Reveals Dynamic Changes in the Magnetic Behavior of Very Small Superparamagnetic Iron Oxide Nanoparticles During Cellular Uptake and Enables Determination of Cell-Labeling Efficacy. | Q38764321 | ||
| Magnetic Nanoparticle Based Nonviral MicroRNA Delivery into Freshly Isolated CD105(+) hMSCs | Q38784475 | ||
| miRNAs: a new method for erythroid differentiation of hematopoietic stem cells without the presence of growth factors. | Q39044656 | ||
| Transplantation of purified autologous leukapheresis-derived CD34+ and CD133+ stem cells for patients with chronic spinal cord injuries: long-term evaluation of safety and efficacy | Q39102872 | ||
| Long term biotransformation and toxicity of dimercaptosuccinic acid-coated magnetic nanoparticles support their use in biomedical applications | Q39116950 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 7152761 | |
| P577 | publication date | 2016-10-04 | |
| P1433 | published in | Stem Cells International | Q26842114 |
| P1476 | title | Magnet-Bead Based MicroRNA Delivery System to Modify CD133+ Stem Cells | |
| P478 | volume | 2016 |
| Q38679832 | Data on the fate of MACS® MicroBeads intramyocardially co-injected with stem cell products |
| Q45867825 | Preparation and In Vitro Characterization of Magnetized miR-modified Endothelial Cells |
| Q89472124 | Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting |
| Q52657125 | Recent Progress in Stem Cell Modification for Cardiac Regeneration. |
Search more.